Dermatology Archives - Infectious Disease Advisor

Mucocutaneous Symptoms of Multisystem Inflammatory Syndrome in Pediatric Patients

By

March 2, 2021

The mucocutaneous features seen in hospitalized children with MIS-C and how these findings are associated with the onset of systemic symptoms are characterized.

COVID19

Are Cutaneous Manifestations Helpful for Diagnosing COVID-19?

By

Brandon May

February 26, 2021

The cutaneous signs thus reported as COVID-19 related, their incidence, clinic-pathologic features, and diagnostic and prognostic values are described.

Whether cryosurgery or cryoablation will prove a viable alternative to lumpectomy — the standard of

General Infectious Disease

Olanexidine Superior to Povidone-Iodine in Reducing Surgical Site Infection

By

Zahra Masoud

November 30, 2020

Study authors compared the effect of aqueous olanexidine and aqueous povidone-iodine on the incidence of surgical site infection following clean-contaminated surgery.

COVID19

COVID-19: Urticaria Skin Manifestations Common With Classic COVID-19 Symptoms

By

Brandon May

November 19, 2020

A literature review assessed English-language studies and case reports that focused on urticaria in patients with COVID-19.

Antibiotics, Antimicrobial Resistance

Dermatologic Challenges to Preventing Antimicrobial Resistance During the COVID-19 Pandemic

By

Linda Peckel

September 14, 2020

The COVID-19 pandemic has illuminated an ongoing concern about antimicrobial resistance in dermatology and requires a recommitment from clinicians to follow guidelines that promote good stewardship.

bald man in hospital bed receiving oxygen

COVID19

COVID-19: Baldness in Men May Be Associated With Increased Infection Risk

By

Emily Pond

August 25, 2020

Men with severe hair loss were significantly more likely to test positive for COVID-19, finds study data.

HIV/AIDS

Brodalumab for the Treatment of Psoriasis in Patients With HIV

By

Emily Pond

July 23, 2020

A first clinical experience with brodalumab in an HIV-positive patient proves successful and may imply the utility of brodalumab in this patient group.

Nosocomial Infections

Mylan Recalls One Lot of Daptomycin for Injection

By

Brian Park, PharmD

July 13, 2020

According to Mylan, the administration of the recalled product may lead to “serious adverse events including, but not limited to, local irritation, vasculitis/phlebitis, antigenic or allergic reactions, and microvascular obstruction, including pulmonary embolism.”

Molluscum contagiosum occurs in approximately 5% to 18% of HIV-infected people, but is becoming rare in areas of the world with good access to highly effective antiretroviral therapies (HAART).16 It is caused by an infection of the epidermal keratinocytes by the molluscum contagiosum virus, a double-stranded DNA virus belonging to the Poxviridae family.16,17 Patients present with small (≤5 mm in diameter), raised lesions that are usually white, pink, or flesh colored with a dimple or pit in the center.17 The lesions are typically smooth, firm, and pearly appearing, and can affect any area of the body, although they are rarely found on the palms or soles. They may occur as solitary lesions or in groups and typically resolve within 6 to 12 months without any scarring.17 Genital lesions may take longer to resolve, and healing times up to 4 years have been reported.16,17 Photo Credit: Medical Images RM/AL LAMME.

Prevention

Berdazimer Sodium Plus Hydrogel Provides Rapid Lesion Clearance in Molluscum Contagiosum

By

Brandon May

November 4, 2019

SB206 12% represents a well-tolerated topical treatment for molluscum contagiosum that can be applied at home by patients or caregivers, solving an unmet medical need.

Antibiotics, Antimicrobial Resistance

Staphylococcus aureus Colonization Associated With Food Sensitization and Allergy, Not Eczema Severity

By

Brandon May

July 30, 2019

The association of S aureus with food sensitization and allergy could influence interventions aimed at inducing and maintaining tolerance to food allergens in eczematous infants.